- Home
- RCKY vs CATX Comparison
RCKY vs CATX Comparison
Compare RCKY & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- CATX
- Stock Information
- Founded
- RCKY 1932
- CATX 1983
- Country
- RCKY United States
- CATX United States
- Employees
- RCKY N/A
- CATX N/A
- Industry
- RCKY Shoe Manufacturing
- CATX Medical/Dental Instruments
- Sector
- RCKY Consumer Discretionary
- CATX Health Care
- Exchange
- RCKY Nasdaq
- CATX Nasdaq
- Market Cap
- RCKY 205.3M
- CATX 239.0M
- IPO Year
- RCKY 1993
- CATX N/A
- Fundamental
- Price
- RCKY $28.98
- CATX $2.35
- Analyst Decision
- RCKY Buy
- CATX Strong Buy
- Analyst Count
- RCKY 1
- CATX 10
- Target Price
- RCKY $40.00
- CATX $12.20
- AVG Volume (30 Days)
- RCKY 108.0K
- CATX 1.8M
- Earning Date
- RCKY 10-28-2025
- CATX 11-10-2025
- Dividend Yield
- RCKY 2.14%
- CATX N/A
- EPS Growth
- RCKY 53.66
- CATX N/A
- EPS
- RCKY 2.74
- CATX N/A
- Revenue
- RCKY $470,314,000.00
- CATX $1,075,000.00
- Revenue This Year
- RCKY $7.09
- CATX N/A
- Revenue Next Year
- RCKY $4.27
- CATX N/A
- P/E Ratio
- RCKY $10.59
- CATX N/A
- Revenue Growth
- RCKY 4.13
- CATX N/A
- 52 Week Low
- RCKY $11.93
- CATX $1.60
- 52 Week High
- RCKY $33.40
- CATX $7.08
- Technical
- Relative Strength Index (RSI)
- RCKY 50.12
- CATX 38.11
- Support Level
- RCKY $28.74
- CATX $2.00
- Resistance Level
- RCKY $31.42
- CATX $2.31
- Average True Range (ATR)
- RCKY 1.45
- CATX 0.19
- MACD
- RCKY -0.03
- CATX 0.02
- Stochastic Oscillator
- RCKY 25.70
- CATX 40.17
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.